News
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 BASIS study (NCT03938792) evaluating HYMPAVZI™ (marstacimab) for adults and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback